Stocks and Investing Stocks and Investing
Fri, December 15, 2023

Ami Fadia Maintained (BCYC) at Strong Buy with Decreased Target to $43 on, Dec 15th, 2023


Published on 2024-10-28 08:01:22 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Decreased Target from $46 to $43 on, Dec 15th, 2023.

Ami has made no other calls on BCYC in the last 4 months.



There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $40 on, Friday, November 3rd, 2023


These are the ratings of the 3 analyists that currently disagree with Ami


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Wednesday, November 8th, 2023
  • Kalpit Patel of "B. Riley Securities" Upgraded from Hold to Strong Buy and Held Target at $33 on, Tuesday, September 12th, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $44 on, Tuesday, September 12th, 2023

Contributing Sources